Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours Β· Estimated delivery Sep 12 - Sep 17
General eligibility: BMI of 30 or greater (clinically defined as obesity), OR BMI of 27 or greater with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea Who should NOT take GLP-1 medications: Personal or family history of medullary thyroid carcinoma (MTC) History of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis Pregnant or breastfeeding patients Patients with severe gastrointestinal disease Our screening process: Your consultation includes a thorough health history review, current medication assessment, and discussion of your weight loss goals
Some of the potential neurological benefits of GLP-1s include: Reduced risk of neurodegenerative diseases like Alzheimers and Parkinsons Improved cognitive function Potential treatment for multiple sclerosis and epilepsy Studies have shown that GLP-1s can increase the number of astrocytes, which help protect the brain and maintain the blood-brain barrier
This optimizes the benefits related to appetite suppression, gastric emptying, and insulin regulation, leading to more predictable weight loss outcomes and better glycemic control
LD 50 values were calculated using the Quest Graph LD 50 Calculator 71
The Lancet Diabetes & Endocrinology, 6(4), 275-286
Accordingly, iron deficiency during various stages of brain development has detrimental consequences
